Sofosbuvir + Ribavirin for 12 or 16 Weeks in Treatment Experienced Subjects With Chronic Genotype 2 or 3 HCV Infection (FUSION)

Clinical trial NCT01604850 · COMPLETED

Trial details

NCT number: NCT01604850
Sponsor: Gilead Sciences
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Hepatitis C

Start date: 2012-06-01
Primary completion: 2013-02-01
Enrollment: 202

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.